Penn Therapeutics CRS (6201) — Philadelphia, Pennsylvania

Penn Therapeutics CRS (6201) is a clinical research site located in Philadelphia, Pennsylvania, United States 19104.

Crixeo Health Trust Score: 53/100 (POOR). This profile has not yet been claimed by the site owner.

Penn Therapeutics CRS (6201) has participated in 2 clinical trials with 1 currently active.

Therapeutic areas: HIV Infections.

Sponsors: Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections.

Sponsor Feasibility Report

Trust Score: 53/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Penn Therapeutics CRS (6201)?

Penn Therapeutics CRS (6201) has a Crixeo Trust Score of 53/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Penn Therapeutics CRS (6201) conducted?

Penn Therapeutics CRS (6201) has 2 clinical trials on record, with 1 currently active. Their work covers HIV Infections.

Is Penn Therapeutics CRS (6201) accredited by Crixeo Health?

Penn Therapeutics CRS (6201) has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Penn Therapeutics CRS (6201)?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.